CFO Moran Sean F. sold 18.0K shares ($863.8K) in 4 separate transactions at Corbus Pharmaceuticals, reducing holdings 27.1%.
Sean F. Moran, Chief Financial Officer of Corbus Pharmaceuticals, executed 4 separate sales totaling 18,043 shares for $863,837.59 between June 14-18, 2024, at prices ranging from $42.12 to $49.87 per share. The sales reduced his holdings from 66,648 shares to 48,605 shares, representing a 27.1% reduction in his position. These sales occur in a company context marked by significant operational challenges: revenue was $0.00 in the latest quarter, the company reported a net loss of $-6,898,771.00, and annual revenue declined 100.0% year-over-year. The CFO's substantial portfolio reduction during a period of acute financial deterioration warrants attention from investors monitoring executive confidence and capital allocation priorities.